In-Hospital Outcome of patients having Acute Myocardial Infarction with and without Streptokinase
Background: Acute myocardial infarction is the leading cause of death. Streptokinase is the most commonly used thrombolytic agent. This study was conducted to compare in-hospital outcome of patients with acute myocardial infarction receiving streptokinase with those not receiving it. Material &...
Main Authors: | Shimal Khan, Amjad Abrar, Abdur Rehman Abid, Tehmina Jan, Habibullah Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Gomal Medical College, D.I.Khan, Pakistan
2009-12-01
|
Series: | Gomal Journal of Medical Sciences |
Online Access: | http://gjms.com.pk/ojs24/index.php/gjms/article/view/172 |
Similar Items
-
Effect of Trimetazidine on Left Ventricular Function in Heart Failure Secondary to Ischemic Heart Disease
by: Shimal Khan, et al.
Published: (2010-06-01) -
INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY
by: Stampfer, M, et al.
Published: (1983) -
Angiographic severity of coronary artery disease in patients with metabolic syndrome
by: Amjad Abrar, et al.
Published: (2012-01-01) -
Bolus streptokinase administration in acute myocardial infarction: features of hypotensive reaction
by: V. A. Stolyarov, et al.
Published: (2005-04-01) -
Safety and Efficacy of Sitagliptin compared with Glimepiride in Patients with Type 2 Diabetes Mellitus inadequately controlled with Metfromin Monotherapy
by: Amjad Abrar, et al.
Published: (2013-07-01)